FRIEDMAN PAUL A sold MDGL
December 10, 2025 · Form 4 insider transaction
FRIEDMAN PAUL A sold 409 shares of Madrigal Pharmaceuticals, Inc. at $549.99 per share, a transaction worth $224.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
409
Price
$549.99
Total value
$224.9K
InsiderFRIEDMAN PAUL A
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 10, 2025
Filing dateDecember 12, 2025
Shares owned after210,396
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $549.27 to $550.23, inclusive.